GalaChain, Through a Monumental Partnership with Shrapnel, Collaborates and Secures Access to China’s Trusted Copyright Chain
Notified -
Globe Newswire30-07-2025, 17:00
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa 15-10-2023, 20:03